source: Boston Scientific Corporation

Boston Scientific Announces Creation of Philanthropic Foundation


NATICK, MA (July 19, 2002) -- Boston Scientific Corporation announced the creation of the Boston Scientific Foundation, a philanthropic organization whose mission is to improve the health of individuals and communities, and to enhance educational opportunity. The Company has funded the Foundation with an initial $18 million endowment.

"We are proud of the long history of philanthropic involvement on the part of our company and our employees," said Jim Tobin, President and Chief Executive Officer of Boston Scientific. "The establishment of the Boston Scientific Foundation continues this commitment while allowing us to increase the impact of our philanthropic activities. We believe the Foundation will serve as an effective vehicle for furthering employees' involvement in their communities and contributing to the common good in the areas of health care and education."

The Foundation will support organizations in communities in the United States where Boston Scientific employees live and work, as well as health care and education initiatives nationwide. Teams consisting of Boston Scientific employees have been established at the Company's major locations throughout the United States to determine where Foundation resources can have the greatest local impact. These teams will assess nonprofit organizations and initiatives in these communities and recommend which ones to support.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices. The Company's products are used in a broad range of interventional medical specialties.

This press release contains forward-looking statements. The Company wishes to caution the reader that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, clinical trials, regulatory approvals, intellectual property, competitive offerings, the Company's overall business strategy, and other factors described in the Company's filings with the Securities and Exchange Commission.


Contacts  
Milan Kofol (508-650-8569)
Investor Relations
Boston Scientific Corporation

Paul Donovan (508-650-8541)
Media Relations
Boston Scientific Corporation